Current Approaches to Skin Cancer Management in Organ Transplant Recipients

NON-MELANOMA SKIN CANCER

Current Approaches to Skin Cancer Management in Organ Transplant Recipients

Mar
2011
Vol. 30. No. 1
Jerry D. Brewer, MD | Meena K. Singh, MD

Approximately 225,000 people are living with organ transplants in the United States. Organ
transplant recipients have a greater risk of developing skin cancer, including basal cell
carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250
times greater incidence of squamous cell carcinoma in certain transplant recipients,
compared with the general population. Because skin cancers are the most common
posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients
is quite significant.
Semin Cutan Med Surg 30:35-47 © 2011 Elsevier Inc. All rights reserved.

PURCHASE NOW